Short answer · Medically reviewed summary · Last updated: 2023-07-13
Systemic Capillary Leak Syndrome (SCLS) is a rare and potentially life-threatening condition characterized by recurrent episodes of severe hypotension, hypoalbuminemia, and hemoconcentration. Although it is a rare disorder, the exact prevalence of SCLS is not well-established due to its underdiagnosis and misdiagnosis. Since SCLS is often misdiagnosed as other conditions such as sepsis or anaphylaxis, it is challenging to determine its true prevalence.
What is the prevalence of Systemic Capillary Leak Syndrome?
Prevalence of Systemic Capillary Leak Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Systemic Capillary Leak Syndrome (SCLS) is a rare and potentially life-threatening condition characterized by recurrent episodes of severe hypotension, hypoalbuminemia, and hemoconcentration. Although it is a rare disorder, the exact prevalence of SCLS is not well-established due to its underdiagnosis and misdiagnosis.
Since SCLS is often misdiagnosed as other conditions such as sepsis or anaphylaxis, it is challenging to determine its true prevalence. However, studies suggest that SCLS affects approximately 1 in 1 million individuals. It is important to note that this estimate may not accurately reflect the actual prevalence, as many cases may go undiagnosed or misclassified.
Given the rarity of SCLS, it is crucial for healthcare professionals to maintain a high index of suspicion when encountering patients with unexplained hypotension, hypoalbuminemia, and hemoconcentration. Early recognition and prompt treatment are essential to improve outcomes and prevent complications associated with this syndrome.
